Rheum4Science: The NLRP3 Inflammasome
R4S-EXP26-NLRP3
Basic & Clinical Sciences
Tuesday, August 22, 2023, 1:00 AM
Thursday, December 31, 2026, 11:55 PM
Participation
Fellows in Training
Rheum4Science
0.00

Activity Overview

The creation of the Rheum4Science program grew out of the conviction that teaching science is important for rheumatologists in training and that adult learners benefit from a variety of resources and formats. Rheum4Science interactive modules teach the underlying immunology and clinical research methodology necessary for the knowledgeable practice of rheumatology.

In this activity, participants will learn about the structure and function of the NLRP3 inflammasome and the important role it plays in several rheumatic diseases.


Rheum4Science Series

This activity is part of a series. See the other activities in the series below.

Rheum4Science – Immunology

Rheum4Science – Immunopathogenesis of Rheumatic Disease

Rheum4Science – Clinical Research Methodology


Registration is complimentary.


Target Audience

Rheumatology fellows in training, medical students, residents, practicing rheumatologists, and other rheumatology health care providers interested in strengthening their understanding of basic scientific principles and clinical research methodology relevant to the field of rheumatology.


Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Understand the structure and function of the NLRP3 inflammasome.
  • Describe the role of the IL-1β in regulating inflammation and auto-inflammation.
  • Recognize that the NLRP3 inflammasome plays an important role in several rheumatic diseases.
  • Describe the structure of the pyrin inflammasome and its role in inflammation.


CE & MOC Information

This activity is not eligible for CME/MOC.


CME Logo



Acknowledgement of Commercial Support

No commercial support was provided for this activity.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.